依布硒啉对大鼠心肌缺血再灌注损伤后磷酸肌醇-3激酶/蛋白激酶B信号通路的影响

doi:10.3877/cma.j.issn.1674-6880.2016.06.002

目的

探讨依布硒啉预处理对大鼠心肌缺血再灌注后磷酸肌醇-3激酶/蛋白激酶B（P13K/Akt）信号及其内质网应激的影响。

方法

将30只大鼠分成对照组，缺血再灌注组及依布硒啉组，每组10只。对照组大鼠冠状动脉左室支左心耳下缘约0.5 cm处只穿线，不结扎，常规腹腔注射生理盐水2 ml；缺血再灌注组大鼠缺血再灌注前30 min腹腔注射生理盐水2 ml；依布硒啉组大鼠缺血再灌注前30 min腹腔注射依布硒啉溶液5 mg/kg。每组各取8只大鼠，采用酶联免疫吸附试验（ELISA）检测各组血清炎症因子高迁移率族蛋白1（HMGB1）、丙二醛、超氧化物歧化酶（SOD）、天冬氨酸转氨酶（AST）及乳酸脱氢酶（LDH）的表达，Tunel法检测缺血心肌细胞凋亡指数，Western-blotting检测各组心肌心肌葡萄糖调节蛋白78（GRP78）蛋白表达及P13K/Akt通路磷酸化水平。

结果

三组大鼠间HMGB1、丙二醛、SOD、AST及LDH水平比较，差异均有统计学意义（F = 63.755、73.023、99.220、110.439、120.557，P均< 0.05），进一步比较发现，缺血再灌注组及依布硒啉组的HMGB1[（9.2 ± 2.7）、（5.5 ± 1.1）、（2.2 ± 0.3）U/L]、丙二醛[（7.2 ± 0.4）、（5.6 ± 0.7）、（4.1 ± 0.9）μmol/L]、AST [（1 011 ± 226）、（813 ± 82）、（671 ± 60）U/L]及LDH [（2 783 ± 674）、（2 043 ± 489）、（1 528 ± 524）U/L]水平较对照组均明显升高，SOD水平[（249 ± 28）、（149 ± 10）、（172 ± 17）kU/L]较对照组明显降低（P均< 0.05）。三组大鼠间的凋亡指数（F = 139.942，P < 0.001）、GRP78蛋白表达（F = 177.846，P < 0.001）及P13K/Akt磷酸化水平（F = 86.286，P < 0.001）比较差异均存在统计学意义，进一步比较发现，缺血再灌注组和依布硒啉组凋亡指数[（38.1 ± 4.6）、（25.4 ± 3.9）、（8.2 ± 1.5）%]明显高于对照组，且I/R组更高（P均< 0.05）。

结论

依布硒啉预处理可以抑制大鼠内质网应激，可能与调节P13K/Akt信号通路磷酸化水平有关。

关键词: 依布硒啉, 再灌注损伤, 磷酸肌醇-3激酶/蛋白激酶B

Objective

To explore the effect of ebselen pretreatment on phosphoinositide 3-kinase/protein kinase B (P13K/Akt) signal pathway and the endoplasmic reticulum stress following ischemia reperfusion (I/R) injury in rats.

Methods

A total of 30 rats were divided into the control group, model group and ebselen group, 10 rats in each group. Rats in the control group were only threaded about 0.5 cm left lower limb at left ventricle coronary artery and recevied 2 ml normal saline intraperitoneal injection. Rats in the model group and ebselen group all established I/R models, and rats in the model group were injected 2 ml normal saline intraperitoneally on 30 min before I/R, while rats in the ebselen group were injected 5 mg/kg ebselen intraperitoneally on 30 min before I/R. Eight rats in each group were used in experiments. The levels of high mobility group box-1 protein (HMGB1), malonaldehyde, superoxide dismutase (SOD), aspartate transaminase (AST) and lactic dehydrogenase (LDH) were detected by enzyme-linked immunosorbent assay (ELISA). The apoptotic index was measured by Tunel method. The expression of glucose regulated protein 78 (GRP78) protein and phosphorylation of P13K/Akt pathway were detected by Western-blotting.

Results

The levels of HMGB1, malonaldehyde, SOD, AST and LDH all showed significant differences among the three groups (F = 63.755, 73.023, 99.220, 110.439, 120.557, all P< 0.05), and the levels of HMGB1 [(9.2 ± 2.7), (5.5 ± 1.1), (2.2 ± 0.3) U/L], malonaldehyde [(7.2 ± 0.4), (5.6 ± 0.7), (4.1 ± 0.9) μmol/L], AST [(1 011 ± 226), (813 ± 82), (671 ± 60) U/L], and LDH [(2 783 ± 674), (2 043 ± 489), (1 528 ± 524) U/L] in the model group and ebselen group were higher, however the SOD [(249 ± 28), (149 ± 10), (172 ± 17) kU/L] were lower than those in the control group (all P< 0.05). Meanwhile, the apoptostic index (F = 139.942, P < 0.001), GRP78 protein (F = 177.846, P < 0.001) and P13K/Akt phosphorylation (F = 86.286, P < 0.001) also had significant differences among the three groups. And the apoptotic index [(38.1 ± 4.6), (25.4 ± 3.9), (8.2 ± 1.5)%] in the model group and ebselen group were higher than that in the control group, and was the highest in the model group (all P < 0.05).

Conclusion

Ebselen pretreatment can inhibit endoplasmic reticulum stress in rats, which may be related to the regulation of P13K/Akt signaling pathway phosphorylation.

Key words: Ebselen, Reperfusion injury, Phosphoinositide 3-kinase/protein kinase B

表1 各组大鼠HMGB1、丙二醛、SOD、AST、LDH的表达（±s）

组别	例数	HMGB1(U/L)	丙二醛(μmol/L)	SOD(kU/L)	AST(U/L)	LDH(U/L)
对照组	8	2.2 ± 0.3	4.1 ± 0.9	249 ± 28	671 ± 60	1528 ± 524
缺血再灌注组	8	9.2 ± 2.7^a	7.2 ± 0.4^a	149 ± 10^a	1011 ± 226^a	2783 ± 674^a
依布硒啉组	8	5.5 ± 1.1^ab	5.6 ± 0.7^ab	172 ± 17^ab	813 ± 82^ab	2043 ± 489^ab
F值	?	63.755	73.023	99.220	110.439	120.557
P值	?	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05

表1 各组大鼠HMGB1、丙二醛、SOD、AST、LDH的表达（±s）

组别	例数	HMGB1(U/L)	丙二醛(μmol/L)	SOD(kU/L)	AST(U/L)	LDH(U/L)
对照组	8	2.2 ± 0.3	4.1 ± 0.9	249 ± 28	671 ± 60	1528 ± 524
缺血再灌注组	8	9.2 ± 2.7^a	7.2 ± 0.4^a	149 ± 10^a	1011 ± 226^a	2783 ± 674^a
依布硒啉组	8	5.5 ± 1.1^ab	5.6 ± 0.7^ab	172 ± 17^ab	813 ± 82^ab	2043 ± 489^ab
F值	?	63.755	73.023	99.220	110.439	120.557
P值	?	< 0.05	< 0.05	< 0.05	< 0.05	< 0.05

图1 三组大鼠心肌细胞凋亡图。注：a图为各组大鼠心肌细胞凋亡指数的比较，与对照组比较，^*P< 0.05，与缺血再灌注组比较，^#P< 0.05（n = 8）；b~d图分别为对照组、缺血再灌注组、依布硒啉组大鼠心肌细胞凋亡情况（Tunel法染色× 400）

图2 三组大鼠GRP78蛋白表达图（n = 8）。注：a图为各组大鼠GRP78蛋白表达比较，与对照组比较，^*P< 0.05，与缺血再灌注组比较，^#P< 0.05；b图为Western-blotting检测各组大鼠心肌GRP78蛋白表达情况；GRP78：葡萄糖调节蛋白78（glucoseregulated protein 78）；GAPDH：3-磷酸甘油醛脱氢酶（glyceraldehyde-3-phosphate dehydrogenase）

图3 三组大鼠P13K/Akt信号通路磷酸化图。注：a图为各组大鼠P13K/Akt信号通路磷酸化水平比较，与对照组比较，^*P< 0.05，与缺血再灌注组比较，^#P< 0.05（n = 8）；b图为Western-blotting检测各组大鼠心肌P13K/Akt信号通路磷酸化情况；P13K/Akt：磷酸肌醇-3激酶/蛋白激酶B（phosphoinositide 3-kinase/protein kinase B）；GAPDH：3-磷酸甘油醛脱氢酶（glyceraldehyde-3-phosphate dehydrogenase）

1	Zhai C,Tang G,Peng L, et al. Inhibition of micro-RNA-1 attenuates hypoxia/re-oxygenation-induced apoptosis of cardiomyocytes by directly targeting Bcl-2 but not GADD45Beta[J]. Am J Transl Res, 2015, 7(10): 1952-1962.
2	翟昌林,唐关敏,胡惠林, 等. 针灸预处理对大鼠心肌缺血再灌注后内质网应激的影响[J/CD]. 中华危重症医学杂志：电子版, 2014, 7(3)：172-176.
3	唐关敏,翟昌林,宋国杰, 等. 针灸联合骨髓间充质干细胞移植对大鼠心肌梗死区心肌重构的影响[J/CD]. 中华危重症医学杂志：电子版, 2014, 7(6)：395-399.
4	Tian Y,Zhang W,Xia D, et al. Postconditioning inhibits myocardial apoptosis during prolonged reperfusion via a JAK2-STAT3-Bcl-2 pathway[J]. J Biomed Sci, 2011(18): 53.
5	Terai K,Hiramoto Y,Masaki M, et al. AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress[J]. Mol Cell Biol, 2005, 25(21): 9554-9575.
6	Nickson P,Toth A,Erhardt P. PUMA is critical for neonatal cardiomyocyte apoptosis induced by endoplasmic reticulum stress[J]. Cardiovasc Res, 2007, 73(1): 48-56.
7	Zhao QF,Xia J,Shao L, et al. Effects of lipoxinA4 on endoplasmic reticulum stress during myocardial ischemia reperfusion injury in rats[J]. Zhonghua Yi Xue Za Zhi, 2013, 93(12): 944-950.
8	Yu L,Lu M,Wang P, et al. Trichostatin A ameliorates myocardial ischemia/reperfusion injury through inhibition of endoplasmic reticulum stress-induced apoptosis[J]. Arch Med Res, 2012, 43(3): 190-196.
9	Aras M,Altas M,Meydan S, et al. Effects of ebselen on ischemia/reperfusion injury in rat brain[J]. Int J Neurosci, 2014, 124(10): 771-776.
10	Tunc T,Uysal B,Atabek C, et al. Erdosteine and ebselen as useful agents in intestinal ischemia/reperfusion injury[J]. J Surg Res, 2009, 155(2): 210-216.
11	Namura S,Nagata I,Takami S, et al. Ebselen reduces cytochrome c release from mitochondria and subsequent DNA fragmentation after transient focal cerebral ischemia in mice[J]. Stroke, 2001, 32(8): 1906-1911.
12	Yang SS,Liu YB,Yu JB, et al. Rapamycin protects heart from ischemia/reperfusion injury independent of autophagy by activating PI3 kinase-Akt pathway and mitochondria K (ATP) channel[J]. Pharmazie, 2010, 65(10): 760-765.
13	Zhang XJ,Xiong ZB,Tang AL, et al. Rosiglitazone-induced myocardial protection against ischaemia- reperfusion injury is mediated via a phosphatidylinositol 3-kinase/Akt-dependent pathway[J]. Clin Exp Pharmacol Physiol, 2010, 37(2): 156-161.
14	Guo J,Bian Y,Bai R, et al. Globular adiponectin attenuates myocardial ischemia/reperfusion injury by upregulating endoplasmic reticulum Ca²⁺-ATPase activity and inhibiting endoplasmic reticulum stress[J]. J Cardiovasc Pharmacol, 2013, 62(2): 143-153.

[1]	史孟杰, 贺仕才, 刘斐, 闫燕, 代毅, 王辉. 对miR-206在大鼠下肢缺血再灌注损伤过程中炎症反应的影响分析[J]. 中华损伤与修复杂志(电子版), 2023, 18(03): 249-255.
[2]	张秀杨, 张龙飞, 陈世远, 高涌. 缺氧诱导因子1α介导单羧酸转运蛋白1表达参与短链脂肪酸对肠道缺氧保护作用的研究[J]. 中华普通外科学文献(电子版), 2023, 17(01): 18-23.
[3]	张星哲, 郑秉暄, 邓格, 豆猛, 石玉婷, 卫田, 郭映聪, 韩锋, 赵艳龙, 丁晨光, 田普训. 髓源性抑制细胞通过抑制炎症反应减轻小鼠肾脏缺血再灌注损伤[J]. 中华移植杂志(电子版), 2023, 17(01): 42-46.
[4]	疏文志, 杨梦凡, 潘斌华, 苏仁义, 林祖源, 杨墨丹, 张镇胜, 宋一粟, 卢正阳, 郑树森, 徐骁, 魏绪勇. 人羊膜上皮干细胞通过调节M1/M2型巨噬细胞极化减轻小鼠肝脏缺血再灌注损伤的实验研究[J]. 中华移植杂志(电子版), 2023, 17(01): 36-41.
[5]	于长江, 赵敏杰, 龚建平. 库普弗细胞在肝移植中的作用研究进展[J]. 中华移植杂志(电子版), 2022, 16(05): 314-318.
[6]	卢强, 杨丽斐, 刘康, 余佳薇, 任璐, 张谞丰, 吕毅. 供肝免冲洗灌注的大鼠肝移植实验研究[J]. 中华肝脏外科手术学电子杂志, 2023, 12(01): 103-107.
[7]	朱任飞, 冯秋琪, 肖锋, 邱烽, 吴建军, 杨帆. 血清肌酸激酶对肝癌肝切除患者缺血-再灌注损伤的预测价值[J]. 中华肝脏外科手术学电子杂志, 2022, 11(05): 482-486.
[8]	张文文, 闫琰, 董毅玲, 覃志成. 外源性硫化氢抑制TLR2和TLR4表达并减轻大鼠肾脏缺血再灌注损伤[J]. 中华肾病研究电子杂志, 2022, 11(02): 61-66.
[9]	关明函, 薛志强. 右美托咪定改善大鼠脑缺血再灌注后脑损伤的研究[J]. 中华神经创伤外科电子杂志, 2023, 09(05): 270-276.
[10]	杨梦琦, 马慧芬, 訾阳, 王楠, 杜冰玉, 常万鹏, 于少泓. 马黛茶对脑血管疾病防治作用的研究进展[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(04): 235-240.
[11]	张敏洁, 张小杉, 段莎莎, 施依璐, 赵捷, 白天昊, 王雅晳. 氢气治疗心肌缺血再灌注损伤的作用机制及展望[J]. 中华临床医师杂志(电子版), 2023, 17(06): 744-748.
[12]	张敏洁, 王雅晳, 段莎莎, 施依璐, 付文艳, 赵海玥, 张小杉. 基于GEO数据库和生物信息学分析筛选大鼠心肌缺血再灌注损伤相关潜在通路和靶点[J]. 中华临床医师杂志(电子版), 2023, 17(04): 438-445.
[13]	蒲友敏, 赵洪雯, 申兵冰, 周强, 谢攀, 吴雄飞. TRPC6靶向miR-214负调控Caspase-1表达以改善肾缺血再灌注损伤的机制研究[J]. 中华临床医师杂志(电子版), 2022, 16(01): 84-93.
[14]	刘志强, 窦项洁, 刘白露, 董晓萌, 鲍俊宇. 银杏达莫注射液对大鼠肝缺血再灌注损伤的保护作用机制研究[J]. 中华诊断学电子杂志, 2022, 10(04): 259-265.
[15]	李宁, 刘言, 林慧庆. 肺移植供肺缺血再灌注损伤的机制及预防[J]. 中华胸部外科电子杂志, 2023, 10(04): 247-256.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Effect of ebselen on phosphoinositide 3-kinase/protein kinase B pathway following myocardial ischemia reperfusion injury in rats

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Effect of ebselen on phosphoinositide 3-kinase/protein kinase B pathway following myocardial ischemia reperfusion injury in rats